Trial Profile
Solithromycin hepatic impairment study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Solithromycin (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- 13 Sep 2013 New trial record